Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Cholangiopathies and the noncoding revolution
Sergio Gradilone
, Nicola Brunetti-Pierri
, Pasquale Piccolo
The Hormel Institute
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cholangiopathies and the noncoding revolution'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-coding RNA (ncRNA)
100%
Non-coding
100%
Cholangiopathy
100%
MicroRNA
66%
Gene Expression
33%
Therapeutic Target
33%
Disease Diagnosis
33%
Non-invasive Biomarkers
33%
Disease Mechanisms
33%
Cholangiocytes
33%
Disease Treatment
33%
Recent Advances
33%
Cholangiocarcinoma
33%
Disease Pathogenesis
33%
Master Regulator
33%
Exponential Growth
33%
Long Non-coding RNA (LncRNA)
33%
Medicine and Dentistry
Bile Duct Disease
100%
microRNA
66%
Diseases
66%
Biological Marker
33%
Gene Expression
33%
Long Untranslated RNA
33%
Cholangiocarcinoma
33%
Cholangiocyte
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Disease
100%
microRNA
66%
Diseases
66%
Biological Marker
33%
Long Untranslated RNA
33%
Bile Duct Carcinoma
33%